MedTrace Logo

Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation

NCT00224341 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2006-10-18

No results posted yet for this study

Summary

The objective of this trial is to show the therapeutic efficacy of the preventive pacing therapies of the Selection 9000 and Vitatron T70 DR pacemakers, dedicated to handle atrial fibrillation (AF). Two new algorithms (post-AF response and ventricular rate stabilization \[VRS\]) will be assessed in a combined pathway, compared to a control group. The efficacy of the overall available therapies to prevent AF and its symptoms will then be assessed also.

Conditions

  • Sick Sinus Syndrome
  • Brady-Tachy Syndrome

Interventions

DEVICE

Pacemaker Vitatron Selection 9000

DEVICE

Pacemaker Vitatron T70

Sponsors & Collaborators

  • Vitatron France

    lead INDUSTRY

Principal Investigators

  • Patrick Attuel, MD · CNOM

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Completion
2006-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00224341 on ClinicalTrials.gov